Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
BMC Cancer|March 2, 2022
A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocolSina Vatandoust, David Wattchow, Luigi Sposato, et al.
Journal of Medical Imaging and Radiation Oncology|October 28, 2014
Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) FrameworkGillian M Duchesne, Mel Grand, Tomas Kron, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerAndrew J Weickhardt, Tim J Price, Geoff Chong, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected]Stephen J Clarke, Sonia Yip, Chris Brown, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
Clinical Endocrinology|April 5, 2013
Predicting vitamin D deficiency in older Australian adultsBich Tran, Bruce K Armstrong, Kevin McGeechan, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
BMC Cancer|March 2, 2022
A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocolSina Vatandoust, David Wattchow, Luigi Sposato, et al.
Journal of Medical Imaging and Radiation Oncology|October 28, 2014
Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) FrameworkGillian M Duchesne, Mel Grand, Tomas Kron, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerAndrew J Weickhardt, Tim J Price, Geoff Chong, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected]Stephen J Clarke, Sonia Yip, Chris Brown, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
Clinical Endocrinology|April 5, 2013
Predicting vitamin D deficiency in older Australian adultsBich Tran, Bruce K Armstrong, Kevin McGeechan, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Pageof 25